Imalux Awarded $2.3 Million Research Grant - home.businesswire.com -Optical Coherence Tomography News

Imalux Awarded $2.3 Million Research Grant

home.businesswire.com Nov 10 2007 Funding

CLEVELAND--(BUSINESS WIRE)--Imalux Corporation (“Imalux”), a medical device company and developer of the Niris™ Imaging System based on Optical Coherence Tomography (“OCT”) technology, today announced the receipt of a Fast-Track research grant from the National Cancer Institute of the National Institutes of Health. The award of up to $2.3 million is to fund Imalux’s accelerated development of video rate Optical Coherence Tomography for early stage cance
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- GlucoLight Corporation Raises Third Tranche Of ''c'' Round Financing also categorized in Funding
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also categorized in Funding
- Imalux Closes Series C Funding Round also categorized in Funding
- Bioptigen Completes Series A Round Funding Investment Closes at $1.3 Million also categorized in Funding
- Lantis Laser (LLSR) Successfully Completes $2.5 Million Financing also categorized in Funding
- Successful OCT imaging during cancer surgery also categorized in Funding
- GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing also categorized in Funding
- OCT market to top $800 million by 2012 also categorized in Funding
- Report identifies $200M OCT market also categorized in Funding

Search:
Categories
1. Applications:
  Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
2. Business News:
  Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
3. Technology:
  Broadband Sources, Probes, Tunable Sources
4. Miscellaneous:
  Jobs & Studentships, Student Theses, Textbooks
Topics Mentioned